Quick Answer
Cocoa Flavanol Blood Pressure Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Among the different forms of the disease, type 2 diabetes mellitus (T2D) accounts for approximately 90–95% of all cases and is strongly associated with insulin resistance, excess adiposity, physical inactivity, and dietary patterns characterized by high consumption of energy-dense, highly processed foods [,].
Key Takeaways
- 01Among the different forms of the disease, type 2 diabetes mellitus (T2D) accounts for approximately 90–95% of all cases and is strongly associated with insulin resistance, excess adiposity, physical inactivity, and dietary patterns characterized by high consumption of energy-dense, highly processed foods [,]. [Tornero-Aguilera Jose Francisco (2026)]
- 026 7 8 Over the past decades, the prevalence of diabetes has increased markedly worldwide, reaching levels of major public health concern. [Tornero-Aguilera Jose Francisco (2026)]
- 03The disease imposes a substantial economic burden on healthcare systems, reduces quality of life, and is associated with a marked increase in mortality risk. [Tornero-Aguilera Jose Francisco (2026)]
- 041 2 3 4 5 Diabetes mellitus comprises a complex and heterogeneous group of metabolic disorders characterized by chronic hyperglycemia resulting from alterations in insulin secretion, insulin action, or a combination of both processes. [Tornero-Aguilera Jose Francisco (2026)]
The current Migaku evidence database contains 2 reusable source documents for Cocoa Flavanol Blood Pressure Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Among the different forms of the disease, type 2 diabetes mellitus (T2D) accounts for approximately 90–95% of all cases and is strongly associated with insulin resistance, excess adiposity, physical inactivity, and dietary patterns characterized by high consumption of energy-dense, highly processed foods [,]. [Tornero-Aguilera Jose Francisco (2026); evidence level 3]
- 6 7 8 Over the past decades, the prevalence of diabetes has increased markedly worldwide, reaching levels of major public health concern. [Tornero-Aguilera Jose Francisco (2026); evidence level 3]
- The disease imposes a substantial economic burden on healthcare systems, reduces quality of life, and is associated with a marked increase in mortality risk. [Tornero-Aguilera Jose Francisco (2026); evidence level 3]
- 1 2 3 4 5 Diabetes mellitus comprises a complex and heterogeneous group of metabolic disorders characterized by chronic hyperglycemia resulting from alterations in insulin secretion, insulin action, or a combination of both processes. [Tornero-Aguilera Jose Francisco (2026); evidence level 3]
- MetS is a multifactorial condition, with its primary indicators including obesity, hypertension, dyslipidemia, insulin resistance, and hyperglycemia; i.e., a patient who possesses at least 3 of the following parameters is designated with MetS: glucose intolerance, increased levels of triglycerides, augmented waist circumference, low levels of high-density lipoprotein cholesterol (HDL-c), and hypertension [,,]. [Tomaru Júlia Mayumi (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources